Antihypertensive and renoprotective efficacy and safety of losartan: A long-term study in children with renal disorders

American Journal of Hypertension

Volumn 17, Issue 10, 2004, Pages 928-935

  Ellis, Demetrius ^a   Moritz, Michael L ^a   Vats, Abhay ^a   Janosky, Janine E ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

GFR; Hypertension; pediatrics; renal disorders

Indexed keywords

LOSARTAN;

ADOLESCENT; ARTICLE; ASTHENIA; BLOOD PRESSURE REGULATION; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPISTAXIS; FATIGUE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEADACHE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NAUSEA; PRIORITY JOURNAL; PROTEINURIA; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VISUAL IMPAIRMENT; VOMITING;

EID: 5444272327     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(04)00875-1     Document Type: Article

References (31)

1. S. Klahr, A.S. Levey, G.J. Beck, A.W. Caggiula, L. Hunsicker, J.W. Kusek, G. Striker The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease N Engl J Med 330 1984 877 884
2. A. Salvetti, P. Mattei, I. Sudano Renal protection and antihypertensive drugs Drugs 57 1999 665 693
3. G. Remuzzi, T. Bertani Pathophysiology of progressive nephropathies N Engl J Med 339 1998 1448 1456
4. M.B. Burton, K.G.P. Harris The role of proteinuria in the progression of chronic renal disease Am J Kidney Dis 27 1996 765 775
5. GISEN Group Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Lancet 349 1997 1857 1863
6. P. Weidmann, M. Schneider, L. Bohlen Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy an updated meta-analysis Nephrol Dial Transplant 19 Suppl 9 1995 39 45
7. E.J. Lewis, L.G. Hunsicker, R.P. Bain, R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
8. M. Praga, E. Hernandez, C. Montoyo, A. Andres, L.M. Ruilope, J.L. Rodicio Long term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria Am J Kidney Dis 20 1992 240 248
9. B.M. Brenner, M.E. Cooper, D. Zeeuw, W.F. Keane, W.E. Mitch, H.H. Parving, G. Remuzzi, S.M. Snapinn, Z. Zhang, S. Shahinfar Renal Study Investigators Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861 869
10. E.J. Lewis, L.G. Hunsicker, W.R. Clarke, T. Berl, M.A. Pohl, J.B. Lewis, E. Ritz, R.C. Atkins, R. Rohde, I. Raz Collaborative Study Group Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 2001 851 860
11. H. Garvas Historical evolution of angiotensin II receptor blockers therapeutic advantages JASN 10 1999 S255 S257
12. H.E. Abboud Growth factors and diabetic nephropathy an overview Kidney Int 52 Suppl 60 1987 S3 S6
13. M. Burnier, H.R. Brunner Angiotensin II receptor antagonists Lancet 355 2000 637 645
14. R. Zatz, R. Dunn, T.W. Meyer, S. Anderson, H.G. Rennke, B.M. Brenner Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension J Clin invest 77 1986 1925 1930
15. S. Anderson, H.G. Rennke, B.M. Brenner Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat J Clin Invest 77 1985 1993 2000
16. S. Anderson, T.W. Meyer, H.G. Rennke, B.M. Brenner Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass J Clin Invest 76 1986 612 619
17. R.T. Gansevoort, D. de Zeeuw, P.E. de Jong Is the proteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system Kidney Int 45 1994 861 867
18. M. Abbate, C. Zoja, D. Rottoli, D. Corna, N. Perico, T. Bertani, G. Remuzzi Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease J Am Soc Nephrol 10 1999 804 813
19. A.V. Kshirsagar, M.S. Joy, S.L. Hogan, R.J. Falk, R.E. Colindres Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease a systematic overview of randomized placebo-controlled trials Am J Kidney Dis 35 2000 695 707
20. P. Zucchelli, A. Zuccala, R. Gaggi Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure Nephrol Dial Transplant 10 Suppl 9 1995 46 51
21. M. Cyr, Y. Lepage, C. Blais Jr, N. Gervais, M. Cugno, J.L. Rouleau, Al Adam Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma Am J Physiol Heart Circ Physiol 281 2001 H275 H283
22. B. Pitt, R. Segal, F.A. Martinez, G. Meurers, A.J. Cowley, I. Thomas, P.C. Deedwania, D.E. Ney, D.B. Snavely, P.I. Chang ELITE Study Investigators Randomized trial of losartan versus captopril in patients over 65 with heart failure Lancet 349 1997 747 752
23. C.E. Stigant, J. Cohen, M. Vivera, J.S. Zaltsman ACE inhibitors and angiotensin II antagonists in renal transplantation an analysis of safety and efficacy Am J Kidney Dis 57 2000 601 606
24. D. Ellis, A. Vats, M. Moritz, S. Reitz, M.J. Grosso, J.E. Janosky Long term anti-proteinuric and renoprotective efficacy and safety of losartan in children with proteinuria J Pediatr 143 2003 89 97
25. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents. A work group report from the National High Blood Pressure Education Program Pediatrics 98 1996 649 658
26. G.J. Schwartz, L.P. Brion, A. Spitzer The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents Pediatr Clin North Am 34 1987 571 590
27. K. Miller, N.C. Santanello, C. Kolman, J. Turpin, T. Rhodes, C. DeMuro-Mercon, V. Frame, W. Shaw, S. Shahinfar Enalapril experience chart review study 2000 Presented at the International Society of Hypertension, 18th Scientific meeting, Chicago, IL, August 20-24, personal communication.
28. M. Soergel, M. Verho, E. Wuhl, J. Gellermann, L. Teichert, K. Scharer Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension Pediatr Nephrol 15 2000 113 118
29. J.T. Flynn, D.A. Pasko Calcium channel blockers pharmacology and place in therapy of pediatric hypertension Pediatr Nephrol 15 2000 302 316
30. M.M. McConnaughey, S. McConnaughey, A.J. Ingenito Practical considerations of the pharmacology of angiotensin receptor blockers J Clin Pharmacol 39 1999 547 559
31. L. Mazzolai, M. Burnier Comparative safety and tolerability of angiotensin II receptor antagonists Drug Safety 21 1999 23 33